The Helmstein bladder distension treatment for tumours and severe bleeding.
The Helmstein bladder distension treatment was applied to 26 patients, who received a total of 70 treatments (52 for bladder tumour and 18 for severe bleeding; in 7 cases for both tumour and bleeding). In the T2 tumours total necrosis occurred in 27% of the cases, partial necrosis in 50% and no necrosis in 23%. Of the patients with total necrosis 64% had recurrences within 12 months. In the T3-T4 tumours only 33% had a temporary slight reduction of the tumour mass. In patients with severe bleeding from the bladder, haematuria ceased within 1 to 5 days after the treatment in 12 out of 18 cases. Bleeding, however, recurred after an average of 3 months. It is concluded that the treatment is useful in selected cases with multiple tumours of the bladder, and the method is effective in controlling severe bleeding from the bladder.
D000368:Aged; D000369:Aged, 80 and over; D003558:Cystoscopy; D005260:Female; D006470:Hemorrhage / Q000628:therapy*; D006801:Humans; D006874:Hydrostatic Pressure / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011312:Pressure / Q000009:adverse effects; D012008:Recurrence; D001745:Urinary Bladder Diseases / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*